KETAMINE (KETALAR)

Question 1

CLASS

Answer 1

NONBARBITUATE ANESTHETIC

Question 2

DESCRIPTION

Answer 2

ACTS ON THE LIMBIC SYSTE AND CORTEX TO BLOCK AFFERENT TRANSMISSION OF IMPULSES ASSOCIATED WITH PAIN PERCEPTION.

Question 3

ONSET & DURATION

Answer 3

ONSET: WITHIN 30 SECONDS
DURATION: 5-10 MINUTES UP TO 1-2 HOURS

Question 4

INDICATIONS

Answer 4

-ANALGESIA, EITHER AS INITIAL AGENT OR WHEN SEVERE PAIN IS REFRACTORY TO OTHER TREATMENTS.
- TREATMENT OF SEVER AGITATION
PROCEDURAL SEDATION
-AS AN ADJUNCT TO NITROUS OXIDE

Question 5

CONTRADICTIONS

Answer 5

STORKE
INCREASED INTRACRANIAL PRESSURE
SEVERE HTN
HISTORY OF SCHIZOPHRENIA EVEN IF CONTROLLED
CARDIAC DECOMPINSATION
HYPERSENSITIVITY

Question 6

ADVERSE REACTIONS

Answer 6

-HTN
-INCREASED HR
-HALLUCINATIONS,DELUSIONS, EXPLICIT DREAMS
-LESS COMMON SIDE EFFECTS: HYPOTENSION, BRADYCARDIA, RESPIRATORY DEPRESSION

Question 7

DRUG INTERACTIONS

Answer 7

MAY INCREASE EFFECTS FROM ETHYL ALCOHOL, OPIOIDS, CNS DEPRESSANTS, AND SELECTIVE SEROTONIN REUPTAKE INHIBITORS

Question 8

HOW KETAMINE IS SUPPLIED

Answer 8

10-, 50-, AND 100- MG/ML VIALS

Question 9

DOSAGE AND ADMINISTRATION

Answer 9

EXCITED DELIRIUM:
2MG/KG IV OVER 1 MINUTE OR 4 MG/KG IM OR IN

PAIN MANAGMENT
MODERATE PAIN: 0.5 MG/G IN ( MAX INITIAL DOSE 25 MG; MAX CUMULATIVE DOSE 100 MG)
SEVERE PAIN: 0.25MG/KG IM,IV,IO( MAX INITIAL DOSE 25 MG; MAX CUMULATIVE DOSE 100 MG)

Question 10

SPECIAL CONSIDERATION

Answer 10

PREGNANCY SAFTEY: CATEGORY C
MAY INCREASE BP, MUSCLE TONE AND HR
DOSAGE NEEDS TO BE INDIVIDUALIZED
KEEP PT IN A QUITE ENVIRONMENT